Article
Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?
European journal of endocrinology - 1 Aug 2007
Savage Martin O, Camacho-Hübner Cecilia, David Alessia, Metherell Louise A, Hwa Vivian, Rosenfeld Ron G, Clark Adrian J L
Abstract excerpt
BACKGROUND: Idiopathic short stature (ISS) includes a range of conditions. Some are caused by defects in the GH-IGF-I axis. ISS is an approved indication for GH therapy in the USA and a similar approval in Europe may be imminent. Genetic analysis for single-gene defects has made enormous contributions to understanding the physiology of growth regulation. Can this type of investigation help in predicting growth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
